nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—CYP2D6—breast cancer	0.296	1	CbGaD
Tetrabenazine—CBR1—Doxorubicin—breast cancer	0.237	0.665	CbGbCtD
Tetrabenazine—CYP2D6—Idarubicin—breast cancer	0.0494	0.139	CbGbCtD
Tetrabenazine—CYP2D6—Vinorelbine—breast cancer	0.0241	0.0677	CbGbCtD
Tetrabenazine—CYP2D6—Tamoxifen—breast cancer	0.0218	0.0611	CbGbCtD
Tetrabenazine—CYP2D6—Vinblastine—breast cancer	0.0149	0.0417	CbGbCtD
Tetrabenazine—CYP2D6—Doxorubicin—breast cancer	0.00913	0.0256	CbGbCtD
Tetrabenazine—CBR1—mammary gland—breast cancer	0.00384	0.105	CbGeAlD
Tetrabenazine—CBR1—nipple—breast cancer	0.00318	0.0868	CbGeAlD
Tetrabenazine—Donepezil—ACHE—breast cancer	0.00308	0.625	CrCbGaD
Tetrabenazine—CBR1—skin of body—breast cancer	0.00203	0.0556	CbGeAlD
Tetrabenazine—CBR1—Vincristine—Vinorelbine—breast cancer	0.00197	0.46	CbGdCrCtD
Tetrabenazine—CBR1—endometrium—breast cancer	0.00192	0.0524	CbGeAlD
Tetrabenazine—CBR1—uterus—breast cancer	0.00177	0.0483	CbGeAlD
Tetrabenazine—CBR1—pituitary gland—breast cancer	0.00174	0.0474	CbGeAlD
Tetrabenazine—CBR1—adipose tissue—breast cancer	0.00173	0.0472	CbGeAlD
Tetrabenazine—SLC18A2—endometrium—breast cancer	0.00165	0.045	CbGeAlD
Tetrabenazine—CBR1—female reproductive system—breast cancer	0.00159	0.0434	CbGeAlD
Tetrabenazine—CBR1—Vincristine—Vinblastine—breast cancer	0.00157	0.367	CbGdCrCtD
Tetrabenazine—CBR1—adrenal gland—breast cancer	0.00155	0.0424	CbGeAlD
Tetrabenazine—SLC18A2—uterus—breast cancer	0.00152	0.0415	CbGeAlD
Tetrabenazine—CBR1—bone marrow—breast cancer	0.0015	0.041	CbGeAlD
Tetrabenazine—SLC18A2—adipose tissue—breast cancer	0.00149	0.0406	CbGeAlD
Tetrabenazine—CBR1—female gonad—breast cancer	0.00145	0.0395	CbGeAlD
Tetrabenazine—SLC18A2—female reproductive system—breast cancer	0.00137	0.0373	CbGeAlD
Tetrabenazine—CBR1—endocrine gland—breast cancer	0.00134	0.0367	CbGeAlD
Tetrabenazine—SLC18A2—adrenal gland—breast cancer	0.00133	0.0364	CbGeAlD
Tetrabenazine—SLC18A2—endocrine gland—breast cancer	0.00116	0.0316	CbGeAlD
Tetrabenazine—Donepezil—CYP2D6—breast cancer	0.000993	0.202	CrCbGaD
Tetrabenazine—CBR1—lymph node—breast cancer	0.00093	0.0254	CbGeAlD
Tetrabenazine—Donepezil—CYP3A4—breast cancer	0.000852	0.173	CrCbGaD
Tetrabenazine—DRD2—pituitary gland—breast cancer	0.00083	0.0227	CbGeAlD
Tetrabenazine—SLC18A2—lymph node—breast cancer	0.000799	0.0218	CbGeAlD
Tetrabenazine—CBR1—Azacitidine—Gemcitabine—breast cancer	0.000742	0.173	CbGdCrCtD
Tetrabenazine—DRD2—endocrine gland—breast cancer	0.000643	0.0176	CbGeAlD
Tetrabenazine—CYP2D6—female reproductive system—breast cancer	0.000456	0.0125	CbGeAlD
Tetrabenazine—CYP2D6—female gonad—breast cancer	0.000415	0.0113	CbGeAlD
Tetrabenazine—CYP2D6—endocrine gland—breast cancer	0.000386	0.0106	CbGeAlD
Tetrabenazine—Eye disorder—Capecitabine—breast cancer	0.000144	0.000683	CcSEcCtD
Tetrabenazine—Osteoarthritis—Doxorubicin—breast cancer	0.000144	0.000681	CcSEcCtD
Tetrabenazine—Cardiac disorder—Capecitabine—breast cancer	0.000143	0.000678	CcSEcCtD
Tetrabenazine—Asthenia—Vinorelbine—breast cancer	0.000142	0.000674	CcSEcCtD
Tetrabenazine—Decreased appetite—Mitoxantrone—breast cancer	0.000142	0.000674	CcSEcCtD
Tetrabenazine—Decreased appetite—Irinotecan—breast cancer	0.000142	0.000674	CcSEcCtD
Tetrabenazine—Dyspnoea—Gemcitabine—breast cancer	0.000142	0.000673	CcSEcCtD
Tetrabenazine—Nausea—Vinblastine—breast cancer	0.000142	0.000672	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Epirubicin—breast cancer	0.000142	0.000672	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Epirubicin—breast cancer	0.000142	0.000672	CcSEcCtD
Tetrabenazine—Insomnia—Fluorouracil—breast cancer	0.000142	0.000672	CcSEcCtD
Tetrabenazine—Somnolence—Gemcitabine—breast cancer	0.000142	0.000671	CcSEcCtD
Tetrabenazine—Fatigue—Irinotecan—breast cancer	0.000141	0.000668	CcSEcCtD
Tetrabenazine—Fatigue—Mitoxantrone—breast cancer	0.000141	0.000668	CcSEcCtD
Tetrabenazine—Vomiting—Goserelin—breast cancer	0.000141	0.000667	CcSEcCtD
Tetrabenazine—Breast disorder—Epirubicin—breast cancer	0.00014	0.000665	CcSEcCtD
Tetrabenazine—Constipation—Mitoxantrone—breast cancer	0.00014	0.000663	CcSEcCtD
Tetrabenazine—Constipation—Irinotecan—breast cancer	0.00014	0.000663	CcSEcCtD
Tetrabenazine—Angiopathy—Capecitabine—breast cancer	0.00014	0.000663	CcSEcCtD
Tetrabenazine—Dyspnoea—Fluorouracil—breast cancer	0.00014	0.000662	CcSEcCtD
Tetrabenazine—Mental disorder—Docetaxel—breast cancer	0.00014	0.000661	CcSEcCtD
Tetrabenazine—Somnolence—Fluorouracil—breast cancer	0.000139	0.00066	CcSEcCtD
Tetrabenazine—Headache—Goserelin—breast cancer	0.000139	0.000658	CcSEcCtD
Tetrabenazine—Anxiety—Paclitaxel—breast cancer	0.000139	0.000657	CcSEcCtD
Tetrabenazine—Decreased appetite—Gemcitabine—breast cancer	0.000139	0.000656	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000138	0.000655	CcSEcCtD
Tetrabenazine—Nausea—Tamoxifen—breast cancer	0.000138	0.000653	CcSEcCtD
Tetrabenazine—Fatigue—Gemcitabine—breast cancer	0.000138	0.000651	CcSEcCtD
Tetrabenazine—Constipation—Gemcitabine—breast cancer	0.000136	0.000646	CcSEcCtD
Tetrabenazine—Decreased appetite—Fluorouracil—breast cancer	0.000136	0.000645	CcSEcCtD
Tetrabenazine—Dry mouth—Paclitaxel—breast cancer	0.000136	0.000645	CcSEcCtD
Tetrabenazine—Asthenia—Thiotepa—breast cancer	0.000136	0.000644	CcSEcCtD
Tetrabenazine—Diarrhoea—Vinorelbine—breast cancer	0.000136	0.000643	CcSEcCtD
Tetrabenazine—Ataxia—Doxorubicin—breast cancer	0.000135	0.00064	CcSEcCtD
Tetrabenazine—Mental disorder—Capecitabine—breast cancer	0.000135	0.00064	CcSEcCtD
Tetrabenazine—Nausea—Melphalan—breast cancer	0.000135	0.000639	CcSEcCtD
Tetrabenazine—Feeling abnormal—Irinotecan—breast cancer	0.000135	0.000639	CcSEcCtD
Tetrabenazine—Feeling abnormal—Mitoxantrone—breast cancer	0.000135	0.000639	CcSEcCtD
Tetrabenazine—Confusional state—Paclitaxel—breast cancer	0.000135	0.000638	CcSEcCtD
Tetrabenazine—Dysphagia—Epirubicin—breast cancer	0.000134	0.000636	CcSEcCtD
Tetrabenazine—Dysuria—Methotrexate—breast cancer	0.000134	0.000635	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Methotrexate—breast cancer	0.000133	0.000631	CcSEcCtD
Tetrabenazine—Nausea—Goserelin—breast cancer	0.000132	0.000623	CcSEcCtD
Tetrabenazine—Feeling abnormal—Gemcitabine—breast cancer	0.000131	0.000622	CcSEcCtD
Tetrabenazine—Dizziness—Vinorelbine—breast cancer	0.000131	0.000622	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Doxorubicin—breast cancer	0.000131	0.000622	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Doxorubicin—breast cancer	0.000131	0.000622	CcSEcCtD
Tetrabenazine—Nervous system disorder—Paclitaxel—breast cancer	0.000131	0.00062	CcSEcCtD
Tetrabenazine—Breast disorder—Doxorubicin—breast cancer	0.00013	0.000615	CcSEcCtD
Tetrabenazine—Diarrhoea—Thiotepa—breast cancer	0.00013	0.000614	CcSEcCtD
Tetrabenazine—Skin disorder—Paclitaxel—breast cancer	0.00013	0.000614	CcSEcCtD
Tetrabenazine—Body temperature increased—Mitoxantrone—breast cancer	0.000129	0.000613	CcSEcCtD
Tetrabenazine—Body temperature increased—Irinotecan—breast cancer	0.000129	0.000613	CcSEcCtD
Tetrabenazine—Feeling abnormal—Fluorouracil—breast cancer	0.000129	0.000612	CcSEcCtD
Tetrabenazine—Bronchitis—Epirubicin—breast cancer	0.000129	0.000611	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Paclitaxel—breast cancer	0.000129	0.000611	CcSEcCtD
Tetrabenazine—Drowsiness—Methotrexate—breast cancer	0.000128	0.000606	CcSEcCtD
Tetrabenazine—Depression—Methotrexate—breast cancer	0.000128	0.000604	CcSEcCtD
Tetrabenazine—Vomiting—Vinorelbine—breast cancer	0.000126	0.000598	CcSEcCtD
Tetrabenazine—Body temperature increased—Gemcitabine—breast cancer	0.000126	0.000597	CcSEcCtD
Tetrabenazine—Tremor—Capecitabine—breast cancer	0.000126	0.000596	CcSEcCtD
Tetrabenazine—Dysuria—Epirubicin—breast cancer	0.000126	0.000594	CcSEcCtD
Tetrabenazine—Dizziness—Thiotepa—breast cancer	0.000125	0.000594	CcSEcCtD
Tetrabenazine—Hypotension—Paclitaxel—breast cancer	0.000125	0.000591	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Epirubicin—breast cancer	0.000125	0.000591	CcSEcCtD
Tetrabenazine—Headache—Vinorelbine—breast cancer	0.000124	0.000589	CcSEcCtD
Tetrabenazine—Dysphagia—Doxorubicin—breast cancer	0.000124	0.000588	CcSEcCtD
Tetrabenazine—Leukopenia—Docetaxel—breast cancer	0.000124	0.000588	CcSEcCtD
Tetrabenazine—Body temperature increased—Fluorouracil—breast cancer	0.000124	0.000587	CcSEcCtD
Tetrabenazine—Sweating—Methotrexate—breast cancer	0.000123	0.000581	CcSEcCtD
Tetrabenazine—Insomnia—Paclitaxel—breast cancer	0.000121	0.000572	CcSEcCtD
Tetrabenazine—Vomiting—Thiotepa—breast cancer	0.000121	0.000571	CcSEcCtD
Tetrabenazine—Leukopenia—Capecitabine—breast cancer	0.00012	0.000569	CcSEcCtD
Tetrabenazine—Drowsiness—Epirubicin—breast cancer	0.00012	0.000567	CcSEcCtD
Tetrabenazine—Bronchitis—Doxorubicin—breast cancer	0.000119	0.000566	CcSEcCtD
Tetrabenazine—Dyspnoea—Paclitaxel—breast cancer	0.000119	0.000564	CcSEcCtD
Tetrabenazine—Headache—Thiotepa—breast cancer	0.000119	0.000562	CcSEcCtD
Tetrabenazine—Somnolence—Paclitaxel—breast cancer	0.000119	0.000562	CcSEcCtD
Tetrabenazine—Nausea—Vinorelbine—breast cancer	0.000118	0.000558	CcSEcCtD
Tetrabenazine—Asthenia—Mitoxantrone—breast cancer	0.000118	0.000556	CcSEcCtD
Tetrabenazine—Asthenia—Irinotecan—breast cancer	0.000118	0.000556	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000117	0.000555	CcSEcCtD
Tetrabenazine—Dysuria—Doxorubicin—breast cancer	0.000116	0.00055	CcSEcCtD
Tetrabenazine—Decreased appetite—Paclitaxel—breast cancer	0.000116	0.00055	CcSEcCtD
Tetrabenazine—Dry mouth—Docetaxel—breast cancer	0.000116	0.000547	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000115	0.000547	CcSEcCtD
Tetrabenazine—Fatigue—Paclitaxel—breast cancer	0.000115	0.000545	CcSEcCtD
Tetrabenazine—Sweating—Epirubicin—breast cancer	0.000115	0.000543	CcSEcCtD
Tetrabenazine—Asthenia—Gemcitabine—breast cancer	0.000114	0.000542	CcSEcCtD
Tetrabenazine—Constipation—Paclitaxel—breast cancer	0.000114	0.000541	CcSEcCtD
Tetrabenazine—Confusional state—Docetaxel—breast cancer	0.000114	0.00054	CcSEcCtD
Tetrabenazine—Anxiety—Capecitabine—breast cancer	0.000114	0.000539	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000114	0.000538	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Methotrexate—breast cancer	0.000113	0.000537	CcSEcCtD
Tetrabenazine—Nausea—Thiotepa—breast cancer	0.000113	0.000533	CcSEcCtD
Tetrabenazine—Urethral disorder—Methotrexate—breast cancer	0.000113	0.000533	CcSEcCtD
Tetrabenazine—Diarrhoea—Mitoxantrone—breast cancer	0.000112	0.00053	CcSEcCtD
Tetrabenazine—Diarrhoea—Irinotecan—breast cancer	0.000112	0.00053	CcSEcCtD
Tetrabenazine—Dry mouth—Capecitabine—breast cancer	0.000112	0.000529	CcSEcCtD
Tetrabenazine—Nervous system disorder—Docetaxel—breast cancer	0.000111	0.000526	CcSEcCtD
Tetrabenazine—Drowsiness—Doxorubicin—breast cancer	0.000111	0.000524	CcSEcCtD
Tetrabenazine—Confusional state—Capecitabine—breast cancer	0.000111	0.000523	CcSEcCtD
Tetrabenazine—Feeling abnormal—Paclitaxel—breast cancer	0.00011	0.000521	CcSEcCtD
Tetrabenazine—Skin disorder—Docetaxel—breast cancer	0.00011	0.000521	CcSEcCtD
Tetrabenazine—Bradycardia—Epirubicin—breast cancer	0.000109	0.000518	CcSEcCtD
Tetrabenazine—Diarrhoea—Gemcitabine—breast cancer	0.000109	0.000517	CcSEcCtD
Tetrabenazine—Dizziness—Irinotecan—breast cancer	0.000108	0.000513	CcSEcCtD
Tetrabenazine—Nervous system disorder—Capecitabine—breast cancer	0.000107	0.000509	CcSEcCtD
Tetrabenazine—Eye disorder—Methotrexate—breast cancer	0.000107	0.000508	CcSEcCtD
Tetrabenazine—Diarrhoea—Fluorouracil—breast cancer	0.000107	0.000508	CcSEcCtD
Tetrabenazine—Cardiac disorder—Methotrexate—breast cancer	0.000107	0.000505	CcSEcCtD
Tetrabenazine—Skin disorder—Capecitabine—breast cancer	0.000106	0.000504	CcSEcCtD
Tetrabenazine—Sweating—Doxorubicin—breast cancer	0.000106	0.000503	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Epirubicin—breast cancer	0.000106	0.000502	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Capecitabine—breast cancer	0.000106	0.000502	CcSEcCtD
Tetrabenazine—Hypotension—Docetaxel—breast cancer	0.000106	0.000501	CcSEcCtD
Tetrabenazine—Body temperature increased—Paclitaxel—breast cancer	0.000106	0.0005	CcSEcCtD
Tetrabenazine—Urethral disorder—Epirubicin—breast cancer	0.000105	0.000499	CcSEcCtD
Tetrabenazine—Angiopathy—Methotrexate—breast cancer	0.000104	0.000493	CcSEcCtD
Tetrabenazine—Vomiting—Irinotecan—breast cancer	0.000104	0.000493	CcSEcCtD
Tetrabenazine—Vomiting—Mitoxantrone—breast cancer	0.000104	0.000493	CcSEcCtD
Tetrabenazine—Dizziness—Fluorouracil—breast cancer	0.000104	0.000491	CcSEcCtD
Tetrabenazine—Headache—Mitoxantrone—breast cancer	0.000103	0.000486	CcSEcCtD
Tetrabenazine—Headache—Irinotecan—breast cancer	0.000103	0.000486	CcSEcCtD
Tetrabenazine—Hypotension—Capecitabine—breast cancer	0.000102	0.000485	CcSEcCtD
Tetrabenazine—Insomnia—Docetaxel—breast cancer	0.000102	0.000485	CcSEcCtD
Tetrabenazine—Vomiting—Gemcitabine—breast cancer	0.000101	0.00048	CcSEcCtD
Tetrabenazine—Bradycardia—Doxorubicin—breast cancer	0.000101	0.000479	CcSEcCtD
Tetrabenazine—Dyspnoea—Docetaxel—breast cancer	0.000101	0.000478	CcSEcCtD
Tetrabenazine—Somnolence—Docetaxel—breast cancer	0.000101	0.000476	CcSEcCtD
Tetrabenazine—Mental disorder—Methotrexate—breast cancer	0.000101	0.000476	CcSEcCtD
Tetrabenazine—Eye disorder—Epirubicin—breast cancer	0.0001	0.000475	CcSEcCtD
Tetrabenazine—Headache—Gemcitabine—breast cancer	9.99e-05	0.000473	CcSEcCtD
Tetrabenazine—Cardiac disorder—Epirubicin—breast cancer	9.98e-05	0.000472	CcSEcCtD
Tetrabenazine—Vomiting—Fluorouracil—breast cancer	9.97e-05	0.000472	CcSEcCtD
Tetrabenazine—Insomnia—Capecitabine—breast cancer	9.91e-05	0.000469	CcSEcCtD
Tetrabenazine—Decreased appetite—Docetaxel—breast cancer	9.84e-05	0.000466	CcSEcCtD
Tetrabenazine—Headache—Fluorouracil—breast cancer	9.83e-05	0.000465	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Doxorubicin—breast cancer	9.82e-05	0.000465	CcSEcCtD
Tetrabenazine—Dyspnoea—Capecitabine—breast cancer	9.77e-05	0.000463	CcSEcCtD
Tetrabenazine—Fatigue—Docetaxel—breast cancer	9.76e-05	0.000462	CcSEcCtD
Tetrabenazine—Angiopathy—Epirubicin—breast cancer	9.75e-05	0.000462	CcSEcCtD
Tetrabenazine—Urethral disorder—Doxorubicin—breast cancer	9.75e-05	0.000461	CcSEcCtD
Tetrabenazine—Nausea—Mitoxantrone—breast cancer	9.73e-05	0.000461	CcSEcCtD
Tetrabenazine—Nausea—Irinotecan—breast cancer	9.73e-05	0.000461	CcSEcCtD
Tetrabenazine—Constipation—Docetaxel—breast cancer	9.68e-05	0.000458	CcSEcCtD
Tetrabenazine—Asthenia—Paclitaxel—breast cancer	9.58e-05	0.000454	CcSEcCtD
Tetrabenazine—Decreased appetite—Capecitabine—breast cancer	9.53e-05	0.000451	CcSEcCtD
Tetrabenazine—Nausea—Gemcitabine—breast cancer	9.48e-05	0.000449	CcSEcCtD
Tetrabenazine—Fatigue—Capecitabine—breast cancer	9.45e-05	0.000447	CcSEcCtD
Tetrabenazine—Mental disorder—Epirubicin—breast cancer	9.42e-05	0.000446	CcSEcCtD
Tetrabenazine—Constipation—Capecitabine—breast cancer	9.37e-05	0.000444	CcSEcCtD
Tetrabenazine—Feeling abnormal—Docetaxel—breast cancer	9.33e-05	0.000442	CcSEcCtD
Tetrabenazine—Nausea—Fluorouracil—breast cancer	9.32e-05	0.000441	CcSEcCtD
Tetrabenazine—Eye disorder—Doxorubicin—breast cancer	9.29e-05	0.00044	CcSEcCtD
Tetrabenazine—Cardiac disorder—Doxorubicin—breast cancer	9.23e-05	0.000437	CcSEcCtD
Tetrabenazine—Tension—Epirubicin—breast cancer	9.18e-05	0.000435	CcSEcCtD
Tetrabenazine—Diarrhoea—Paclitaxel—breast cancer	9.14e-05	0.000433	CcSEcCtD
Tetrabenazine—Nervousness—Epirubicin—breast cancer	9.09e-05	0.00043	CcSEcCtD
Tetrabenazine—Feeling abnormal—Capecitabine—breast cancer	9.03e-05	0.000428	CcSEcCtD
Tetrabenazine—Angiopathy—Doxorubicin—breast cancer	9.02e-05	0.000427	CcSEcCtD
Tetrabenazine—Body temperature increased—Docetaxel—breast cancer	8.95e-05	0.000424	CcSEcCtD
Tetrabenazine—Leukopenia—Methotrexate—breast cancer	8.95e-05	0.000424	CcSEcCtD
Tetrabenazine—Dizziness—Paclitaxel—breast cancer	8.83e-05	0.000418	CcSEcCtD
Tetrabenazine—Mental disorder—Doxorubicin—breast cancer	8.71e-05	0.000412	CcSEcCtD
Tetrabenazine—Body temperature increased—Capecitabine—breast cancer	8.67e-05	0.00041	CcSEcCtD
Tetrabenazine—Agitation—Epirubicin—breast cancer	8.6e-05	0.000407	CcSEcCtD
Tetrabenazine—Tension—Doxorubicin—breast cancer	8.5e-05	0.000402	CcSEcCtD
Tetrabenazine—Vomiting—Paclitaxel—breast cancer	8.49e-05	0.000402	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	8.45e-05	0.0004	CcSEcCtD
Tetrabenazine—Nervousness—Doxorubicin—breast cancer	8.41e-05	0.000398	CcSEcCtD
Tetrabenazine—Leukopenia—Epirubicin—breast cancer	8.38e-05	0.000396	CcSEcCtD
Tetrabenazine—Headache—Paclitaxel—breast cancer	8.37e-05	0.000396	CcSEcCtD
Tetrabenazine—Confusional state—Methotrexate—breast cancer	8.23e-05	0.000389	CcSEcCtD
Tetrabenazine—Asthenia—Docetaxel—breast cancer	8.12e-05	0.000385	CcSEcCtD
Tetrabenazine—Nervous system disorder—Methotrexate—breast cancer	8e-05	0.000379	CcSEcCtD
Tetrabenazine—Agitation—Doxorubicin—breast cancer	7.96e-05	0.000377	CcSEcCtD
Tetrabenazine—Anxiety—Epirubicin—breast cancer	7.94e-05	0.000376	CcSEcCtD
Tetrabenazine—Nausea—Paclitaxel—breast cancer	7.93e-05	0.000376	CcSEcCtD
Tetrabenazine—Skin disorder—Methotrexate—breast cancer	7.93e-05	0.000375	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	7.91e-05	0.000374	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Methotrexate—breast cancer	7.89e-05	0.000373	CcSEcCtD
Tetrabenazine—Asthenia—Capecitabine—breast cancer	7.86e-05	0.000372	CcSEcCtD
Tetrabenazine—Dry mouth—Epirubicin—breast cancer	7.79e-05	0.000369	CcSEcCtD
Tetrabenazine—Leukopenia—Doxorubicin—breast cancer	7.75e-05	0.000367	CcSEcCtD
Tetrabenazine—Diarrhoea—Docetaxel—breast cancer	7.75e-05	0.000367	CcSEcCtD
Tetrabenazine—Confusional state—Epirubicin—breast cancer	7.7e-05	0.000364	CcSEcCtD
Tetrabenazine—Hypotension—Methotrexate—breast cancer	7.63e-05	0.000361	CcSEcCtD
Tetrabenazine—Diarrhoea—Capecitabine—breast cancer	7.5e-05	0.000355	CcSEcCtD
Tetrabenazine—Nervous system disorder—Epirubicin—breast cancer	7.49e-05	0.000354	CcSEcCtD
Tetrabenazine—Dizziness—Docetaxel—breast cancer	7.49e-05	0.000354	CcSEcCtD
Tetrabenazine—Skin disorder—Epirubicin—breast cancer	7.42e-05	0.000351	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Epirubicin—breast cancer	7.38e-05	0.000349	CcSEcCtD
Tetrabenazine—Insomnia—Methotrexate—breast cancer	7.38e-05	0.000349	CcSEcCtD
Tetrabenazine—Anxiety—Doxorubicin—breast cancer	7.35e-05	0.000348	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.32e-05	0.000346	CcSEcCtD
Tetrabenazine—Dyspnoea—Methotrexate—breast cancer	7.28e-05	0.000344	CcSEcCtD
Tetrabenazine—Somnolence—Methotrexate—breast cancer	7.25e-05	0.000343	CcSEcCtD
Tetrabenazine—Dizziness—Capecitabine—breast cancer	7.25e-05	0.000343	CcSEcCtD
Tetrabenazine—Dry mouth—Doxorubicin—breast cancer	7.21e-05	0.000341	CcSEcCtD
Tetrabenazine—Vomiting—Docetaxel—breast cancer	7.2e-05	0.000341	CcSEcCtD
Tetrabenazine—Hypotension—Epirubicin—breast cancer	7.14e-05	0.000338	CcSEcCtD
Tetrabenazine—Confusional state—Doxorubicin—breast cancer	7.12e-05	0.000337	CcSEcCtD
Tetrabenazine—Decreased appetite—Methotrexate—breast cancer	7.09e-05	0.000336	CcSEcCtD
Tetrabenazine—Headache—Docetaxel—breast cancer	7.09e-05	0.000336	CcSEcCtD
Tetrabenazine—Fatigue—Methotrexate—breast cancer	7.04e-05	0.000333	CcSEcCtD
Tetrabenazine—Vomiting—Capecitabine—breast cancer	6.97e-05	0.00033	CcSEcCtD
Tetrabenazine—Nervous system disorder—Doxorubicin—breast cancer	6.93e-05	0.000328	CcSEcCtD
Tetrabenazine—Insomnia—Epirubicin—breast cancer	6.91e-05	0.000327	CcSEcCtD
Tetrabenazine—Headache—Capecitabine—breast cancer	6.87e-05	0.000325	CcSEcCtD
Tetrabenazine—Skin disorder—Doxorubicin—breast cancer	6.86e-05	0.000325	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Doxorubicin—breast cancer	6.83e-05	0.000323	CcSEcCtD
Tetrabenazine—Dyspnoea—Epirubicin—breast cancer	6.81e-05	0.000322	CcSEcCtD
Tetrabenazine—Somnolence—Epirubicin—breast cancer	6.79e-05	0.000321	CcSEcCtD
Tetrabenazine—Nausea—Docetaxel—breast cancer	6.73e-05	0.000318	CcSEcCtD
Tetrabenazine—Feeling abnormal—Methotrexate—breast cancer	6.72e-05	0.000318	CcSEcCtD
Tetrabenazine—Decreased appetite—Epirubicin—breast cancer	6.64e-05	0.000314	CcSEcCtD
Tetrabenazine—Hypotension—Doxorubicin—breast cancer	6.6e-05	0.000313	CcSEcCtD
Tetrabenazine—Fatigue—Epirubicin—breast cancer	6.58e-05	0.000312	CcSEcCtD
Tetrabenazine—Constipation—Epirubicin—breast cancer	6.53e-05	0.000309	CcSEcCtD
Tetrabenazine—Nausea—Capecitabine—breast cancer	6.51e-05	0.000308	CcSEcCtD
Tetrabenazine—Body temperature increased—Methotrexate—breast cancer	6.45e-05	0.000305	CcSEcCtD
Tetrabenazine—Insomnia—Doxorubicin—breast cancer	6.39e-05	0.000303	CcSEcCtD
Tetrabenazine—Dyspnoea—Doxorubicin—breast cancer	6.3e-05	0.000298	CcSEcCtD
Tetrabenazine—Feeling abnormal—Epirubicin—breast cancer	6.29e-05	0.000298	CcSEcCtD
Tetrabenazine—Somnolence—Doxorubicin—breast cancer	6.28e-05	0.000297	CcSEcCtD
Tetrabenazine—Decreased appetite—Doxorubicin—breast cancer	6.14e-05	0.000291	CcSEcCtD
Tetrabenazine—Fatigue—Doxorubicin—breast cancer	6.09e-05	0.000288	CcSEcCtD
Tetrabenazine—Constipation—Doxorubicin—breast cancer	6.04e-05	0.000286	CcSEcCtD
Tetrabenazine—Body temperature increased—Epirubicin—breast cancer	6.04e-05	0.000286	CcSEcCtD
Tetrabenazine—Asthenia—Methotrexate—breast cancer	5.85e-05	0.000277	CcSEcCtD
Tetrabenazine—Feeling abnormal—Doxorubicin—breast cancer	5.82e-05	0.000276	CcSEcCtD
Tetrabenazine—Body temperature increased—Doxorubicin—breast cancer	5.59e-05	0.000264	CcSEcCtD
Tetrabenazine—Diarrhoea—Methotrexate—breast cancer	5.58e-05	0.000264	CcSEcCtD
Tetrabenazine—Asthenia—Epirubicin—breast cancer	5.48e-05	0.000259	CcSEcCtD
Tetrabenazine—Dizziness—Methotrexate—breast cancer	5.4e-05	0.000255	CcSEcCtD
Tetrabenazine—Diarrhoea—Epirubicin—breast cancer	5.22e-05	0.000247	CcSEcCtD
Tetrabenazine—Vomiting—Methotrexate—breast cancer	5.19e-05	0.000246	CcSEcCtD
Tetrabenazine—Headache—Methotrexate—breast cancer	5.11e-05	0.000242	CcSEcCtD
Tetrabenazine—Asthenia—Doxorubicin—breast cancer	5.07e-05	0.00024	CcSEcCtD
Tetrabenazine—Dizziness—Epirubicin—breast cancer	5.05e-05	0.000239	CcSEcCtD
Tetrabenazine—Vomiting—Epirubicin—breast cancer	4.86e-05	0.00023	CcSEcCtD
Tetrabenazine—Nausea—Methotrexate—breast cancer	4.85e-05	0.000229	CcSEcCtD
Tetrabenazine—Diarrhoea—Doxorubicin—breast cancer	4.83e-05	0.000229	CcSEcCtD
Tetrabenazine—Headache—Epirubicin—breast cancer	4.78e-05	0.000226	CcSEcCtD
Tetrabenazine—Dizziness—Doxorubicin—breast cancer	4.67e-05	0.000221	CcSEcCtD
Tetrabenazine—Nausea—Epirubicin—breast cancer	4.54e-05	0.000215	CcSEcCtD
Tetrabenazine—Vomiting—Doxorubicin—breast cancer	4.49e-05	0.000213	CcSEcCtD
Tetrabenazine—Headache—Doxorubicin—breast cancer	4.43e-05	0.00021	CcSEcCtD
Tetrabenazine—Nausea—Doxorubicin—breast cancer	4.2e-05	0.000199	CcSEcCtD
Tetrabenazine—DRD2—Signaling Pathways—CDH5—breast cancer	2.44e-05	0.000271	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CALCA—breast cancer	2.4e-05	0.000266	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EDNRB—breast cancer	2.4e-05	0.000266	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SFRP2—breast cancer	2.4e-05	0.000266	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PRLR—breast cancer	2.35e-05	0.000261	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CXCR4—breast cancer	2.35e-05	0.00026	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CXCL12—breast cancer	2.35e-05	0.00026	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GLI2—breast cancer	2.27e-05	0.000252	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VCP—breast cancer	2.27e-05	0.000252	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	2.26e-05	0.000251	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SHMT1—breast cancer	2.25e-05	0.000249	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CDA—breast cancer	2.25e-05	0.000249	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LEPR—breast cancer	2.23e-05	0.000248	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CALCA—breast cancer	2.18e-05	0.000242	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC2A5—breast cancer	2.16e-05	0.00024	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLCO1B1—breast cancer	2.16e-05	0.00024	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CXCR4—breast cancer	2.13e-05	0.000236	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CXCL12—breast cancer	2.13e-05	0.000236	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AGTR1—breast cancer	2.12e-05	0.000235	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—APRT—breast cancer	2.09e-05	0.000232	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ARHGDIA—breast cancer	2.08e-05	0.00023	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FST—breast cancer	2.02e-05	0.000224	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HEY2—breast cancer	2e-05	0.000222	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RPS6KB2—breast cancer	1.98e-05	0.000219	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TP53—breast cancer	1.98e-05	0.000219	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ESRRA—breast cancer	1.97e-05	0.000218	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ANGPTL4—breast cancer	1.97e-05	0.000218	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RGS2—breast cancer	1.95e-05	0.000217	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCL20—breast cancer	1.93e-05	0.000214	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AGTR1—breast cancer	1.93e-05	0.000214	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ITPR1—breast cancer	1.9e-05	0.000211	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TLE3—breast cancer	1.87e-05	0.000207	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LPAR1—breast cancer	1.87e-05	0.000207	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HADHB—breast cancer	1.86e-05	0.000207	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GPI—breast cancer	1.86e-05	0.000207	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HEY1—breast cancer	1.85e-05	0.000205	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—DLL1—breast cancer	1.82e-05	0.000201	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—IL6—breast cancer	1.81e-05	0.000201	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HIST1H2BC—breast cancer	1.78e-05	0.000198	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HIST1H2BK—breast cancer	1.78e-05	0.000198	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALDH7A1—breast cancer	1.78e-05	0.000197	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALDH1A1—breast cancer	1.78e-05	0.000197	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CA—breast cancer	1.77e-05	0.000197	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PDE4D—breast cancer	1.77e-05	0.000196	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GRB7—breast cancer	1.77e-05	0.000196	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CSF2—breast cancer	1.76e-05	0.000195	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TAB2—breast cancer	1.74e-05	0.000192	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ITPR1—breast cancer	1.73e-05	0.000192	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CNR2—breast cancer	1.72e-05	0.000191	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CXCL8—breast cancer	1.72e-05	0.000191	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MMP3—breast cancer	1.72e-05	0.00019	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NME1—breast cancer	1.7e-05	0.000189	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PHGDH—breast cancer	1.7e-05	0.000189	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—UMPS—breast cancer	1.7e-05	0.000189	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ADSL—breast cancer	1.7e-05	0.000189	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—FHL2—breast cancer	1.7e-05	0.000189	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—DKK1—breast cancer	1.68e-05	0.000186	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—LDHB—breast cancer	1.67e-05	0.000185	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—BRIP1—breast cancer	1.67e-05	0.000185	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HPSE—breast cancer	1.67e-05	0.000185	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFC—breast cancer	1.67e-05	0.000185	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JAG2—breast cancer	1.64e-05	0.000182	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—WNT1—breast cancer	1.62e-05	0.000179	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PLA2G4A—breast cancer	1.61e-05	0.000179	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CSF2—breast cancer	1.6e-05	0.000177	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCC1—breast cancer	1.58e-05	0.000176	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA3—breast cancer	1.58e-05	0.000176	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HMMR—breast cancer	1.58e-05	0.000176	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPARGC1B—breast cancer	1.53e-05	0.00017	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOTCH4—breast cancer	1.53e-05	0.00017	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GZMB—breast cancer	1.52e-05	0.000169	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AGTR2—breast cancer	1.48e-05	0.000164	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCL2—breast cancer	1.48e-05	0.000164	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTHLH—breast cancer	1.46e-05	0.000162	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—BMP2—breast cancer	1.46e-05	0.000162	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKT1—breast cancer	1.45e-05	0.000161	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA4—breast cancer	1.45e-05	0.000161	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CA9—breast cancer	1.45e-05	0.000161	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EDNRB—breast cancer	1.42e-05	0.000157	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GPX2—breast cancer	1.41e-05	0.000157	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA2—breast cancer	1.41e-05	0.000157	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PGR—breast cancer	1.4e-05	0.000156	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—THBS1—breast cancer	1.4e-05	0.000155	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GPX4—breast cancer	1.39e-05	0.000155	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SULT1A1—breast cancer	1.39e-05	0.000155	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—IDH1—breast cancer	1.36e-05	0.000151	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA1—breast cancer	1.36e-05	0.000151	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NAT2—breast cancer	1.35e-05	0.000149	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FLT1—breast cancer	1.33e-05	0.000148	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGF3—breast cancer	1.33e-05	0.000147	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SQSTM1—breast cancer	1.33e-05	0.000147	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CG—breast cancer	1.32e-05	0.000146	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JAG1—breast cancer	1.31e-05	0.000145	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PARP1—breast cancer	1.3e-05	0.000145	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOTCH3—breast cancer	1.3e-05	0.000145	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CALCA—breast cancer	1.29e-05	0.000143	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RPS6—breast cancer	1.27e-05	0.000141	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGF4—breast cancer	1.26e-05	0.00014	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCR4—breast cancer	1.26e-05	0.00014	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCL12—breast cancer	1.26e-05	0.00014	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PAK1—breast cancer	1.24e-05	0.000137	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TCF7L2—breast cancer	1.21e-05	0.000135	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AKT2—breast cancer	1.21e-05	0.000134	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CG—breast cancer	1.2e-05	0.000133	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MED12—breast cancer	1.18e-05	0.000131	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—DPYD—breast cancer	1.18e-05	0.000131	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HSP90AA1—breast cancer	1.17e-05	0.00013	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOTCH2—breast cancer	1.17e-05	0.00013	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALDOA—breast cancer	1.16e-05	0.000129	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CD—breast cancer	1.16e-05	0.000129	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PRL—breast cancer	1.14e-05	0.000126	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AGTR1—breast cancer	1.14e-05	0.000126	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOA3—breast cancer	1.13e-05	0.000125	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STK11—breast cancer	1.12e-05	0.000124	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADAM10—breast cancer	1.12e-05	0.000124	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC2A2—breast cancer	1.12e-05	0.000124	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PLG—breast cancer	1.11e-05	0.000123	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTR—breast cancer	1.1e-05	0.000122	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCG2—breast cancer	1.1e-05	0.000122	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CPT1A—breast cancer	1.1e-05	0.000122	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AKT2—breast cancer	1.1e-05	0.000122	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGF10—breast cancer	1.09e-05	0.000121	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HPGDS—breast cancer	1.08e-05	0.000119	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HBA1—breast cancer	1.07e-05	0.000119	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CD—breast cancer	1.05e-05	0.000117	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PDGFA—breast cancer	1.05e-05	0.000117	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ACHE—breast cancer	1.04e-05	0.000116	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTT1—breast cancer	1.04e-05	0.000116	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TGFBR2—breast cancer	1.04e-05	0.000115	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ITPR1—breast cancer	1.02e-05	0.000113	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ERBB4—breast cancer	1.01e-05	0.000112	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STAT5A—breast cancer	1.01e-05	0.000112	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MMP3—breast cancer	1.01e-05	0.000112	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CB—breast cancer	1.01e-05	0.000112	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP17A1—breast cancer	9.89e-06	0.00011	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SMAD4—breast cancer	9.82e-06	0.000109	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTGS1—breast cancer	9.79e-06	0.000109	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ENO1—breast cancer	9.79e-06	0.000109	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF1R—breast cancer	9.76e-06	0.000108	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CXCL8—breast cancer	9.72e-06	0.000108	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HES1—breast cancer	9.59e-06	0.000106	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NCOR1—breast cancer	9.54e-06	0.000106	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PLA2G4A—breast cancer	9.54e-06	0.000106	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGF1—breast cancer	9.43e-06	0.000105	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CSF2—breast cancer	9.43e-06	0.000105	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOA2—breast cancer	9.42e-06	0.000104	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—RAF1—breast cancer	9.41e-06	0.000104	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NRG1—breast cancer	9.36e-06	0.000104	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—H2AFX—breast cancer	9.29e-06	0.000103	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—IL2—breast cancer	9.29e-06	0.000103	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—E2F1—breast cancer	9.23e-06	0.000102	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CB—breast cancer	9.18e-06	0.000102	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—FASN—breast cancer	9.14e-06	0.000101	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—BCHE—breast cancer	9.1e-06	0.000101	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC5A5—breast cancer	8.99e-06	9.97e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SPP1—breast cancer	8.86e-06	9.83e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CXCL8—breast cancer	8.83e-06	9.79e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ERBB3—breast cancer	8.77e-06	9.73e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGFR2—breast cancer	8.75e-06	9.71e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NQO1—breast cancer	8.68e-06	9.63e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC2A1—breast cancer	8.68e-06	9.63e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP3A4—breast cancer	8.46e-06	9.39e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL2—breast cancer	8.43e-06	9.36e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TERT—breast cancer	8.4e-06	9.32e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP1B1—breast cancer	8.32e-06	9.23e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HSP90AA1—breast cancer	8.16e-06	9.05e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGFR1—breast cancer	8.16e-06	9.05e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HIF1A—breast cancer	8.04e-06	8.91e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOA1—breast cancer	7.94e-06	8.81e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LEP—breast cancer	7.85e-06	8.7e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP19A1—breast cancer	7.82e-06	8.68e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—STK11—breast cancer	7.82e-06	8.68e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CAV1—breast cancer	7.77e-06	8.62e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KDR—breast cancer	7.69e-06	8.53e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ESR1—breast cancer	7.49e-06	8.31e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FN1—breast cancer	7.4e-06	8.21e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NFKBIA—breast cancer	7.31e-06	8.11e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—COMT—breast cancer	7.27e-06	8.07e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOTCH1—breast cancer	7.24e-06	8.03e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTP1—breast cancer	7.24e-06	8.03e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HMOX1—breast cancer	7.14e-06	7.92e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ITPR1—breast cancer	7.12e-06	7.9e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CG—breast cancer	7.08e-06	7.85e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KIT—breast cancer	7.08e-06	7.85e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—APC—breast cancer	7.08e-06	7.85e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EGF—breast cancer	7e-06	7.76e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCB1—breast cancer	6.85e-06	7.6e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MAPK3—breast cancer	6.78e-06	7.52e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TYMS—breast cancer	6.73e-06	7.46e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—BRAF—breast cancer	6.66e-06	7.38e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PLA2G4A—breast cancer	6.65e-06	7.38e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOR1—breast cancer	6.65e-06	7.38e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTM1—breast cancer	6.65e-06	7.38e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF1—breast cancer	6.48e-06	7.19e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKT2—breast cancer	6.48e-06	7.19e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EGFR—breast cancer	6.45e-06	7.16e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GPX1—breast cancer	6.37e-06	7.07e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP1A1—breast cancer	6.31e-06	6.99e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ERCC2—breast cancer	6.25e-06	6.94e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CD—breast cancer	6.22e-06	6.9e-05	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	6.17e-06	6.84e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SERPINE1—breast cancer	6.16e-06	6.83e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—KRAS—breast cancer	6.09e-06	6.76e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTHFR—breast cancer	5.88e-06	6.52e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOS3—breast cancer	5.88e-06	6.52e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CA—breast cancer	5.6e-06	6.21e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MDM2—breast cancer	5.58e-06	6.19e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RAF1—breast cancer	5.56e-06	6.16e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RELA—breast cancer	5.53e-06	6.14e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ERBB2—breast cancer	5.5e-06	6.1e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CB—breast cancer	5.43e-06	6.02e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MTOR—breast cancer	5.43e-06	6.02e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CAV1—breast cancer	5.42e-06	6.02e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCL8—breast cancer	5.21e-06	5.78e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—HRAS—breast cancer	5.18e-06	5.75e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN1B—breast cancer	5.09e-06	5.65e-05	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AKT1—breast cancer	5.04e-06	5.59e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CASP3—breast cancer	4.99e-06	5.54e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL2—breast cancer	4.98e-06	5.53e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL6—breast cancer	4.96e-06	5.5e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CG—breast cancer	4.94e-06	5.48e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCND1—breast cancer	4.86e-06	5.39e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JUN—breast cancer	4.85e-06	5.38e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CTNNB1—breast cancer	4.81e-06	5.34e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MMP9—breast cancer	4.72e-06	5.23e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN1A—breast cancer	4.7e-06	5.21e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTEN—breast cancer	4.69e-06	5.2e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAPK8—breast cancer	4.59e-06	5.09e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AKT1—breast cancer	4.57e-06	5.07e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SRC—breast cancer	4.35e-06	4.82e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CD—breast cancer	4.34e-06	4.82e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALB—breast cancer	4.29e-06	4.75e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFA—breast cancer	4.23e-06	4.7e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STAT3—breast cancer	4.19e-06	4.65e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NOS3—breast cancer	4.1e-06	4.55e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAPK3—breast cancer	4.01e-06	4.44e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MYC—breast cancer	3.9e-06	4.32e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TGFB1—breast cancer	3.89e-06	4.31e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EGFR—breast cancer	3.81e-06	4.23e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CB—breast cancer	3.78e-06	4.2e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTGS2—breast cancer	3.75e-06	4.16e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KRAS—breast cancer	3.6e-06	3.99e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CA—breast cancer	3.31e-06	3.67e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTEN—breast cancer	3.27e-06	3.63e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TP53—breast cancer	3.2e-06	3.55e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HRAS—breast cancer	3.06e-06	3.39e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL6—breast cancer	2.93e-06	3.25e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKT1—breast cancer	2.7e-06	3e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CA—breast cancer	2.31e-06	2.56e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKT1—breast cancer	1.88e-06	2.09e-05	CbGpPWpGaD
